These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4381308)

  • 1. The effect of o,p'DDD on cortisol and hexobarbital metabolism.
    Kupfer D; Peets L
    Biochem Pharmacol; 1966 May; 15(5):573-81. PubMed ID: 4381308
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of chlorinated hydrocarbons and organophosphate insecticides on metabolism of steroids.
    Kupfer D
    Ann N Y Acad Sci; 1969; 160(1):244-53. PubMed ID: 4389893
    [No Abstract]   [Full Text] [Related]  

  • 3. Alteration in the magnitude of induction of tyrosine transaminase by glycocorticoids. The effects of phenobarbital, o,p'DDD and beta-diethylaminoethyl diphenylpropylacetate (SKF 525A).
    Kupfer D
    Arch Biochem Biophys; 1968 Sep; 127(1):200-6. PubMed ID: 4386644
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors influencing steroid hydroxylases in liver microsomes.
    Kuntzman R; Welch R; Conney AH
    Adv Enzyme Regul; 1966; 4():149-60. PubMed ID: 4169942
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of cortisol metabolism in vitro by 2-methylnaphthoquinone (menadione): a possible interpretation of the potentiation of cortisol activity in vivo.
    Kupfer D; Peets L
    Experientia; 1968 Sep; 24(9):893-4. PubMed ID: 4387793
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of various chemical agents on drug metabolism and cholesterol biosynthesis.
    Mitoma C; Yasuda D; Tagg JS; Neubauer SE; Calderoni FJ; Tanabe M
    Biochem Pharmacol; 1968 Jul; 17(7):1377-83. PubMed ID: 5659782
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of drug metabolism. VI. Inhibition of hexobarbital metabolism in the isolated perfused liver of the rat.
    Stitzel RE; Tephly TR; Mannering GJ
    Mol Pharmacol; 1968 Jan; 4(1):15-9. PubMed ID: 5640777
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereoselective hydroxylation of hexobarbital enantiomers by rat liver microsomes.
    Miyano K; Fujii Y; Toki S
    Drug Metab Dispos; 1980; 8(2):104-10. PubMed ID: 6103782
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of drug metabolism. IV. Induction of drug metabolism by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and 2,4-dichloro-6-phenylphenoxyethylamine HBr (Lilly 18947) and the effect of induction on the inhibitory properties of SKF 525-A type compounds.
    Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):341-6. PubMed ID: 5968074
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results.
    Faggiano A; Leboulleux S; Young J; Schlumberger M; Baudin E
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):110-3. PubMed ID: 16402938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL; McCarthy JS; Stitzel RE; Anders MW
    J Pharmacol Exp Ther; 1969 Oct; 169(2):153-8. PubMed ID: 5824599
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of cytochrome P-450-dependent aminopyrine N-demethylase in rat brain: comparison with hepatic aminopyrine N-demethylation.
    Marietta MP; Vesell ES; Hartman RD; Weisz J; Dvorchik BH
    J Pharmacol Exp Ther; 1979 Feb; 208(2):271-9. PubMed ID: 33263
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of hexobarbital metabolism by Morris hepatoma 5123tc.
    Hickie RA; Kalant H
    Can J Physiol Pharmacol; 1967 Nov; 45(6):975-83. PubMed ID: 4294213
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of microsomal drug metabolism by methylenedioxybenzenes.
    Anders MW
    Biochem Pharmacol; 1968 Nov; 17(11):2367-70. PubMed ID: 5718145
    [No Abstract]   [Full Text] [Related]  

  • 16. Spectral studies of drug interaction with hepatic microsomal cytochrome.
    Schenkman JB; Remmer H; Estabrook RW
    Mol Pharmacol; 1967 Mar; 3(2):113-23. PubMed ID: 4382749
    [No Abstract]   [Full Text] [Related]  

  • 17. A sensitive radioactive assay for hexobarbital hydroxylase in hepatic microsomes.
    Kupfer D; Rosenfeld J
    Drug Metab Dispos; 1973; 1(6):760-5. PubMed ID: 4156298
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of drug metabolism. V. Inhibition of drug metabolism by steroids.
    Tephly TR; Mannering GJ
    Mol Pharmacol; 1968 Jan; 4(1):10-4. PubMed ID: 5640776
    [No Abstract]   [Full Text] [Related]  

  • 19. The metabolic fate of hexobarbital in the rat.
    Holcomb RR; Gerber N; Bush MT
    J Pharmacol Exp Ther; 1974 Jan; 188(1):15-26. PubMed ID: 4809266
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of the pharmacology of o,p'DDD in man.
    MOY RH
    J Lab Clin Med; 1961 Aug; 58():296-304. PubMed ID: 13773354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.